Abstract

Matrine is an alkaloid isolated from the medicinal plant Sophora flavescens Ait (Leguminosae) with various pharmacological and physiological effects. Here, we investigate its combined effects with imatinib, a specific tyrosine kinase inhibitor used clinically against leukemia cells, on bcr/abl-positive leukemia K562 cells. The results indicate that matrine enhanced imatinib-induced apoptosis in K562 cells through downregulation of protein levels of bcr/abl and phospho-Erk1/2.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.